A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

Withdrawn National Institute of Allergy and Infectious Diseases (NIAID)

RandomizedTreatment

Summary

The purpose of this trial is to study L-735,524, which is an inhibitor of the HIV protease enzyme. It will be used with interleukin-2 in patients infected with HIV.

Timeline

Start: —
Primary completion: 2002-08
Completion: 2002-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	INDINAVIR ANHYDROUS	Other / unclassified	—	—

A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

Summary

Timeline

Drugs

Indications